What are the recommended intravenous (IV) fluconazole dosing, preparation, infusion rate, and renal dose adjustments for adults and pediatric patients?

Intravenous Fluconazole Administration

Administer IV fluconazole at a maximum infusion rate of 200 mg/hour as a continuous infusion, with dosing based on indication: 200-800 mg loading dose followed by 100-400 mg daily for adults, and weight-based dosing for pediatrics (3-12 mg/kg daily depending on indication and age). 1

Preparation and Administration

Infusion Rate and Method:

• Maximum infusion rate: 200 mg/hour as continuous infusion 1
• Administer using sterile equipment only
• Inspect solution visually before administration - discard if cloudy, precipitated, or seal is not intact 1
• Do NOT add supplementary medications to the fluconazole solution 1
• Critical pitfall: Always flush the infusion line after administration to prevent significant drug loss (up to 33% of dose can be lost without flushing) 2

Adult Dosing by Indication

Oropharyngeal Candidiasis

• 200 mg loading dose on day 1, then 100 mg daily for at least 14 days 1

Esophageal Candidiasis

• 200 mg loading dose on day 1, then 100 mg daily (may increase to 400 mg daily based on response) 3, 1
• When oral therapy not tolerated: 400 mg (6 mg/kg) IV daily 3
• Minimum treatment: 3 weeks and at least 2 weeks after symptom resolution 1

Systemic Candida Infections (Candidemia, Disseminated)

• Up to 400 mg daily (optimal dose not fully established) 1

Empiric Therapy in ICU Patients

• 800 mg (12 mg/kg) loading dose, then 400 mg (6 mg/kg) daily for high-risk ICU patients 3

Cryptococcal Meningitis

• Acute treatment: 400 mg loading dose on day 1, then 200-400 mg daily 1
• Duration: 10-12 weeks after CSF becomes culture-negative 1
• Suppression therapy (AIDS patients): 200 mg daily 1

Bone Marrow Transplant Prophylaxis

• 400 mg daily starting several days before anticipated neutropenia, continuing 7 days after neutrophil count >1000 cells/mm³ 1

Pediatric Dosing

Oropharyngeal Candidiasis (≥6 months)

• 6 mg/kg loading dose on day 1, then 3 mg/kg daily for at least 14 days 1

Esophageal Candidiasis (≥6 months)

• 6 mg/kg loading dose on day 1, then 3 mg/kg daily (may increase to 12 mg/kg/day based on response) 1
• Minimum: 3 weeks and at least 2 weeks after symptom resolution 1

Systemic Candida Infections

Age ≥3 months:

• 25 mg/kg loading dose on day 1 (max 800 mg), then 12 mg/kg daily (max 400 mg) 1

Birth to 3 months, gestational age ≥30 weeks:

• 25 mg/kg loading dose on day 1, then 12 mg/kg daily 1

Birth to 3 months, gestational age <30 weeks:

• 25 mg/kg loading dose on day 1, then 9 mg/kg daily 1

Important note: Neonates have prolonged elimination half-lives (88.6 hours at birth, decreasing to 55.2 hours by 2 weeks) 4. Some sources recommend dosing every 72 hours in the first 2 weeks of life, then every 48 hours in weeks 2-4 5.

Pediatric Patients on ECMO

Age ≥3 months:

• 35 mg/kg loading dose on day 1 (max 800 mg), then 12 mg/kg daily (max 400 mg) 1

Birth to 3 months, gestational age ≥30 weeks:

• 35 mg/kg loading dose, then 12 mg/kg daily 1

Birth to 3 months, gestational age <30 weeks:

• 35 mg/kg loading dose, then 9 mg/kg daily 1

Cryptococcal Meningitis (Pediatric)

• 12 mg/kg loading dose on day 1, then 6 mg/kg daily (may use 12 mg/kg daily based on response) 1
• Duration: 10-12 weeks after CSF culture-negative 1
• Suppression (AIDS): 6 mg/kg daily 1

Renal Dose Adjustments

Fluconazole is cleared primarily by renal excretion (approximately 65% of total clearance is renal) 1, 6. Dosing adjustments are essential in renal impairment.

Adult Renal Dosing Algorithm:

1. Give initial loading dose (50-400 mg based on indication) 1

2. Adjust maintenance dose based on creatinine clearance:

   • CrCl >50 mL/min: 100% of normal dose 1
   • CrCl ≤50 mL/min (no dialysis): 50% of normal dose 1
   • Hemodialysis: 100% of recommended dose after each dialysis session; on non-dialysis days, give reduced dose per CrCl 1

3. Calculate CrCl if only serum creatinine available:

   • Males: [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)] 1
   • Females: 0.85 × male value 1

Pediatric Renal Dosing:

• Follow same principles as adults 1
• Pediatric CrCl formula: [K × height (cm)] / serum creatinine (mg/dL)
  • K = 0.55 for children >1 year
  • K = 0.45 for infants 1

Special Populations:

Critically ill patients on CVVHD: Recent evidence shows standard dosing is insufficient. Start with at least 400 mg twice daily to achieve target attainment in 100% of patients 7. Current guidelines (12 mg/kg loading, then 6 mg/kg daily) achieve adequate exposure only for MIC ≤1 mg/L 8.

Continuous ambulatory peritoneal dialysis:

• 150 mg in 2L dialysis solution every 2 days 9

Key Clinical Considerations

Pharmacokinetic Principles:

• Long elimination half-life (31.6 hours in adults) requires 6 days to reach steady-state; loading dose recommended 9
• Children have shorter half-lives (~20 hours) and higher clearance than adults, except neonates 4, 6
• Volume of distribution: 0.7 L/kg in adults, higher in neonates (1.18-2.25 L/kg) 9, 4
• Low protein binding (11-12%) - circulates as active drug 9
• Bioavailability ~90% (oral and IV are interchangeable once patient can tolerate oral intake) 9

Therapeutic Drug Monitoring:

• Target plasma concentrations: 4-20 mcg/mL 5
• Consider monitoring in neonates, renal impairment, and critically ill patients

Common Pitfalls:

• Failing to flush IV lines results in 10-33% drug loss 2
• Inadequate dosing in CRRT/ECMO patients leads to treatment failure 7, 8
• Forgetting to adjust for renal function causes drug accumulation
• Premature discontinuation increases relapse risk 3